Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Nasopharyngeal Carcinoma 20Squamous Cell Carcinoma of Head and Neck 7Oropharyngeal Neoplasms 7Prostatic Neoplasms 5Carcinoma 4Rectal Neoplasms 3Nasopharyngeal Neoplasms 3Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Stomatitis 2Pancreatic Adenocarcinoma 2Neoplasm Metastasis 2Meningeal Carcinomatosis 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Tumor Virus Infections 1Thyroid Carcinoma, Anaplastic 1Stomatognathic Diseases 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Sarcoma 1Recurrence 1

Interventions

Cyclophosphamide 28fludarabine 19Rituximab 17obinutuzumab 12venetoclax 10Lenalidomide 9Bendamustine Hydrochloride 9Prednisone 7zanubrutinib 6Doxorubicin 6Blood Specimen Collection 6pembrolizumab 5ibrutinib 5fludarabine phosphate 5Biopsy 5glofitamab 4Vincristine 4Trimethoprim, Sulfamethoxazole Drug Combination 4Exercise 4loncastuximab tesirine 3gamma-Globulins 3axicabtagene ciloleucel 3acalabrutinib 3Temozolomide 3Surveys and Questionnaires 3Palliative Care 3Mycophenolic Acid 3Methotrexate 3Mesna 3Magnetic Resonance Spectroscopy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphoma × Radiotherapy, Intensity-Modulated × Clear all
NCT05371132 2026-01-28

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

City of Hope Medical Center

Phase 1 Recruiting
10 enrolled
Lymphoid

Lymphoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡